NO973251L - Fremgangsmåte for å forebygge transplantat avstötelse - Google Patents

Fremgangsmåte for å forebygge transplantat avstötelse

Info

Publication number
NO973251L
NO973251L NO973251A NO973251A NO973251L NO 973251 L NO973251 L NO 973251L NO 973251 A NO973251 A NO 973251A NO 973251 A NO973251 A NO 973251A NO 973251 L NO973251 L NO 973251L
Authority
NO
Norway
Prior art keywords
donor tissue
photosensitizer
tissue
apc
exposing
Prior art date
Application number
NO973251A
Other languages
English (en)
Other versions
NO973251D0 (no
Inventor
Julia Levy
Modestus Onuora Kay Obochi
Original Assignee
Quadra Logic Tech Inc
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc, Univ British Columbia filed Critical Quadra Logic Tech Inc
Publication of NO973251D0 publication Critical patent/NO973251D0/no
Publication of NO973251L publication Critical patent/NO973251L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Transplanting Machines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

En fremgangsmåte for å redusere avstøtelse av allografter omfattende donorvev inneholdende antigenpresenterende celler (APC) er beskrevet. Fremgangsmåten omfatter: a) kontakting av donorvevet med et fotosensibiliserende middel for å oppnå et modifisert donorvev; b) eksponering av det modifiserte donorvevet for lys med en bølgelengde som blir absorbert av det fotosensibiliserende middelet i et tidsrom som er tilstrekkelig for å tape APC i donorvevet; og c) transplantering av APC-tappet donorvev inn i vevet til en mottager. Ved å utsette donorvev for fotodynamisk terapi ble den gjennomsnittlige overlevelsestiden til podningene, spesilt hudallografter, betydelig forlenget. Det fotosensibiliserende middelet kan også være en del av et konjugat inneholdende en mål-spesifikk del.
NO973251A 1995-01-13 1997-07-11 Fremgangsmåte for å forebygge transplantat avstötelse NO973251L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37170795A 1995-01-13 1995-01-13
PCT/CA1996/000019 WO1996021466A1 (en) 1995-01-13 1996-01-12 Method to prevent transplant rejection

Publications (2)

Publication Number Publication Date
NO973251D0 NO973251D0 (no) 1997-07-11
NO973251L true NO973251L (no) 1997-09-08

Family

ID=23465087

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973251A NO973251L (no) 1995-01-13 1997-07-11 Fremgangsmåte for å forebygge transplantat avstötelse

Country Status (18)

Country Link
EP (1) EP0804238B1 (no)
JP (1) JP3702330B2 (no)
KR (1) KR19980701317A (no)
CN (1) CN1192157A (no)
AT (1) ATE277636T1 (no)
AU (1) AU693634B2 (no)
CA (1) CA2210109C (no)
CZ (1) CZ214697A3 (no)
DE (1) DE69633494T2 (no)
ES (1) ES2227578T3 (no)
FI (1) FI972953A (no)
HU (1) HUP9801123A3 (no)
NO (1) NO973251L (no)
NZ (1) NZ298355A (no)
PL (1) PL321246A1 (no)
SK (1) SK93797A3 (no)
TW (1) TW426518B (no)
WO (1) WO1996021466A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882328A (en) * 1995-01-13 1999-03-16 Qlt Phototherapeutics, Inc. Method to prevent transplant rejection
US5789433A (en) * 1995-01-17 1998-08-04 Quadra Logic Technologies, Inc. Green porphyrins as immunomodulators
US6096776A (en) * 1995-01-17 2000-08-01 Qlt Phototherapeutics, Inc. Green porphyrins as immunomodulators
US6107325A (en) * 1995-01-17 2000-08-22 Qlt Phototherapeutics, Inc. Green porphyrins as immunomodulators
US5824080A (en) * 1995-09-28 1998-10-20 The General Hospital Corporation Photochemistry for the preparation of biologic grafts--allografts and xenografts
EP0981371A1 (en) * 1997-05-16 2000-03-01 QLT Phototherapeutics, Inc. Green porphyrins as immunomodulators
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
US6197294B1 (en) 1998-10-26 2001-03-06 Neurotech S.A. Cell surface molecule-induced macrophage activation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028594A (en) * 1988-12-27 1991-07-02 Naxcor Use of photodynamic compositions for cytotoxic effects
US5147289A (en) * 1990-03-29 1992-09-15 Therakos, Inc Non-specific immune system enhancement
US5820872A (en) * 1992-11-18 1998-10-13 Yale University Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor

Also Published As

Publication number Publication date
AU4381896A (en) 1996-07-31
FI972953A (fi) 1997-09-08
CA2210109A1 (en) 1996-07-18
JP3702330B2 (ja) 2005-10-05
EP0804238B1 (en) 2004-09-29
DE69633494D1 (de) 2004-11-04
ATE277636T1 (de) 2004-10-15
JP2001526623A (ja) 2001-12-18
CZ214697A3 (en) 1997-12-17
CN1192157A (zh) 1998-09-02
KR19980701317A (ko) 1998-05-15
ES2227578T3 (es) 2005-04-01
NO973251D0 (no) 1997-07-11
HUP9801123A3 (en) 1999-12-28
MX9705268A (es) 1997-10-31
FI972953A0 (fi) 1997-07-11
SK93797A3 (en) 1998-01-14
PL321246A1 (en) 1997-11-24
TW426518B (en) 2001-03-21
CA2210109C (en) 2008-09-23
WO1996021466A1 (en) 1996-07-18
EP0804238A1 (en) 1997-11-05
NZ298355A (en) 2000-02-28
DE69633494T2 (de) 2005-10-20
HUP9801123A2 (hu) 1998-08-28
AU693634B2 (en) 1998-07-02

Similar Documents

Publication Publication Date Title
CA2346644A1 (en) Method for preventing xenograft transplant rejection using photodynamic therapy
EP0637976A1 (en) LASER TREATMENT.
AR011285A1 (es) Metodo in vitro para modificar el tejido donante, el tejido donante y un tejido de injerto obtenido por dicho metodo y una composicion de material parallevar a cabo dicho metodo.
IL122382A0 (en) Ultra-long flashlamp-excited pulse dye laser for therapy and method therefor
ZA871407B (en) Light array assembly for photoactivation patient treatment system
ES2167611T3 (es) Formulaciones de gel que contienen factores de crecimiento.
FI981954A (fi) Parannettu näkökyky silmän fotodynaamisen terapian avulla
AU1931495A (en) Treated tissue for implantation and preparation methods
NZ336196A (en) Use of green porphyrins for the treatment of secondary cataracts
NO973251L (no) Fremgangsmåte for å forebygge transplantat avstötelse
PT97785A (pt) Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina
O'DONOGHUE et al. Stimulation of neovascularization—comparative efficacy of fresh and preserved skin grafts
EP0313901A3 (en) System for in vivo treatment of tumorous tissues on body surfaces
BR0014135A (pt) Composição farmacêutica fotoativável para destruição e/ou inaticação seletivas de células imunologicamente reativas, uso da mesma, e, métodos para prevenção de doença de enxerto-versus-hospedeiro associada com transplante alogênico de células tronco em um paciente, para tratamento de distúrbio imunológico em um paciente e para avaliar o mecanismo de transporte de células imunes e/ou malignas
HK1028190A1 (en) Compositions and articles for reducing the effectsof inflammation.
PH24585A (en) Irradiation chamber for photoactivation patient treatment system
ATE62599T1 (de) Verwendung einer loesung von alpha-chymotrypsin.
Pandya et al. The absence of vascularization in porcine skin grafts on mice
Barner Allogenic vein as a conduit for coronary artery bypass
Bottiroli Effects of low-power light on biological systems; Proceedings of the Meeting, San Remo, Italy, Sept. 8, 1997
RUBALTELLI et al. Tin-protoporphyrin in the Management of Children With Crigler-Najjar Disease
UA10224A (uk) Спосіб лікування хронічного бронхіту на фоні цукрового діабету
BG60887B1 (en) Thienethiopyran sulphonamide derivatives and their application in ophthalmological preparations
徐承熊 et al. PURGE OF MALIGNANT CELLS FROM BONE MARROW BY HEMATOPORPHYRIN DERIVATIVES AND LIGHT EXPOSURE IN VITRO
RU97113329A (ru) Способ лечения больных с двс-синдромом и гипокоагуляцией после кровотечения при травме органов брюшной полости

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application